GSK

LONDON, July 30, 2026 GSK has announced plans to establish a new global flagship research and development (R&D) centre...

BOULDER, Colo., July 28, 2026 Ambrosia Biosciences Inc. has strengthened its leadership team and scientific capabilities with the appointment...

LONDON, July 30, 2026 GSK has reported strong Q2 2026 financial results, driven by continued growth across its Specialty...

Caesarea, Israel, July 27, 2026 IceCure Medical Ltd. has announced the launch of its post-marketing ChoICE Study, with the...

London, July 27, 2026 ViiV Healthcare has announced positive Week 48 results from the Phase IIIb VOGUE study, demonstrating...

PITTSBURGH, Pa., July 23, 2026 Xodus Medical has announced encouraging results from a new observational clinical study demonstrating that...

LONDON, United Kingdom, July 23, 2026 GSK plc has announced that the U.S. Food and Drug Administration (FDA) has...

LONDON, United Kingdom, May 20, 2026 GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved...

SAN FRANCISCO, May 6, 2026 Artera announced that the U.S. Food and Drug Administration (FDA) has granted clearance for...

SUZHOU, China, May 6, 2026 SiranBio announced a major global licensing agreement with GSK for its investigational siRNA therapeutic...